Loading...
•
Jun 30, 2022
IDEX Q2 2022 Earnings Report
IDEX reported strong results, achieving double-digit organic sales growth and record adjusted EPS.
Key Takeaways
IDEX Corporation reported strong second-quarter results with a 16% increase in sales, driven by 12% organic growth. The company achieved record adjusted EPS of $2.02, a 15% increase year-over-year. Operating margin performance remained strong, and the company completed the acquisition of KZValve.
Reported EPS of $1.81, up 35% and record adjusted EPS of $2.02, up 15% vs. Q2 2021
Orders of $839 million, up 12% overall and 7% organically vs. Q2 2021
Record sales of $796 million, up 16% overall and 12% organically vs. Q2 2021
Completed acquisition of KZValve on May 2, 2022
IDEX
IDEX
IDEX Revenue by Segment
Revenue by Segment
Health & Science Technologies Revenue
CapyFin.comFluid & Metering Technologies Revenue
CapyFin.comFire & Safety/Diversified Products Revenue
CapyFin.com Forward Guidance
Full year 2022 organic sales growth is projected to be approximately 10 percent, with a 9 to 10 percent organic sales increase in the third quarter of 2022 versus the prior year period. The Company expects full year 2022 reported EPS attributable to IDEX of $7.19 to $7.29 (adjusted EPS attributable to IDEX of $7.88 to $7.98) and third quarter 2022 reported EPS attributable to IDEX of $1.80 to $1.85 (adjusted EPS attributable to IDEX of $1.98 to $2.03).
Positive Outlook
- Full year 2022 organic sales growth is projected to be approximately 10 percent.
- Organic sales are expected to increase 9-10% in Q3 2022 compared to the prior year.
- Full year 2022 reported EPS attributable to IDEX is guided to $7.19 - $7.29.
- Full year 2022 adjusted EPS attributable to IDEX is guided to $7.88 - $7.98.
- Third quarter 2022 reported EPS attributable to IDEX is expected to be $1.80 - $1.85.
Revenue & Expenses
Visualization of income flow from segment revenue to net income